Heyholder
‹ Activism Filings

CJ Bioscience Paid-in Capital Increase Decision

CJ Bioscience

AI summary · Not investment advice

Subsidiary EzBiome will issue 185,667 new shares at KRW 40,671 each to raise KRW 7.3 billion for debt repayment and KRW 0.3 billion for operations.

New shares · common

185,667 shares

Key facts

Issue price per share
KRW 40,671
Offering method
Rights offering to existing shareholders
Working capital
KRW 299.6 million
Debt repayment
KRW 7.3 billion

Commentary

AI commentary · Not investment advice

What happened

CJ Bioscience's subsidiary EzBiome decided to issue 185,667 new common shares to raise money. It is a rights offering to existing shareholders (new shares are offered to current holders first). The issue price is KRW 40,671 per share.

In the company's terms

The money has two uses. KRW 7.25 billion goes to repaying debt, and KRW 299.6 million goes to operating funds.

What changes for shareholders

Before the offering, EzBiome had 99,444 common shares. Each existing share entitles the holder to 1.867050 new shares. The right to subscribe to new shares cannot be transferred to others. Payment for the new shares is scheduled for Nov 23, 2026.

Comments

No comments yet

Comments from shareholders will appear here.